France has just the use of chloroquine to treat COVID-19, this after trials yielded favorable outcomes in 78 of 80 patients treated in trials.
Now, the Food and Drug Administration has issued an emergency authorization for this anti-malaria drug, and private firms have been donating millions of doses of chloroquine and hydroxychloroquine to the fight.
Others have cautioned that a long period of human trials should take place first, but these drugs have been around for decades, treating patients, and I think the determination has been made that the potential benefits outweigh the potential risks.
Fingers crossed.
No comments:
Post a Comment